InsiderClue
Insiders · Profile

Williams Timothy

SVP & General Counsel at Vanda Pharmaceuticals. Filing since 14 Aug 2019. CIK 0001748392

Company
Date
Role
Action
Shares
Amount
Of holding
VNDA Vanda Pharmaceuticals Inc.
2 Mar 2026
SVP & General Counsel
Sold at will
42,434
$350.76K
10.1%
VNDA Vanda Pharmaceuticals Inc.
5 Mar 2024
SVP & General Counsel
Sold at will
8,941
$37.40K
4.3%
VNDA Vanda Pharmaceuticals Inc.
4 Mar 2024
SVP & General Counsel
Sold at will
8,147
$35.92K
3.8%
VNDA Vanda Pharmaceuticals Inc.
13 Jun 2023
SVP & General Counsel
Sold at will
14,600
$95.75K
14.1%
VNDA Vanda Pharmaceuticals Inc.
3 Mar 2023
SVP & General Counsel
Sold, plan not stated
8,301
$51.89K
7.4%
VNDA Vanda Pharmaceuticals Inc.
2 Mar 2023
SVP & General Counsel
Sold, plan not stated
8,437
$52.68K
7.0%
VNDA Vanda Pharmaceuticals Inc.
15 Dec 2022
SVP & General Counsel
Sold, plan not stated
8,000
$56.07K
8.4%
VNDA Vanda Pharmaceuticals Inc.
15 Aug 2022
SVP & General Counsel
Sold, plan not stated
8,300
$85.50K
8.0%
VNDA Vanda Pharmaceuticals Inc.
2 Mar 2022
SVP & General Counsel
Sold, plan not stated
12,060
$133.78K
10.4%
VNDA Vanda Pharmaceuticals Inc.
16 Aug 2021
SVP & General Counsel
Sold, plan not stated
3,715
$59.99K
4.3%
VNDA Vanda Pharmaceuticals Inc.
5 Mar 2021
SVP & General Counsel
Sold, plan not stated
5,600
$99.97K
6.1%
VNDA Vanda Pharmaceuticals Inc.
2 Mar 2021
SVP & General Counsel
Sold, plan not stated
7,674
$142.31K
7.7%
VNDA Vanda Pharmaceuticals Inc.
1 Mar 2021
SVP & General Counsel
Sold, plan not stated
11,856
$220.54K
10.6%
VNDA Vanda Pharmaceuticals Inc.
14 Aug 2020
SVP & General Counsel
Sold, plan not stated
3,684
$43.53K
4.4%
VNDA Vanda Pharmaceuticals Inc.
3 Mar 2020
SVP & General Counsel
Sold, plan not stated
1,237
$13.00K
1.5%
VNDA Vanda Pharmaceuticals Inc.
2 Mar 2020
SVP & General Counsel
Sold, plan not stated
3,148
$32.44K
3.6%
VNDA Vanda Pharmaceuticals Inc.
14 Aug 2019
SVP & General Counsel
Sold, plan not stated
2,575
$37.83K
4.3%
17 decisions on file.